Dreyton Amador

Dreyton Amador

Auto-generated profile, based on publicly available information

Dreyton Amador

Synthetic Regeneration and Systems Physiology Laboratory, Columbia Stem Cell Initiative, Columbia Data Science Institute, Naomi Berrie Diabetes Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AOAlonso Ortega-Gurrola
Alonso Ortega-Gurrola
MKMayra Kalaora
Mayra Kalaora
DADreyton Amador
Dreyton Amador
JWJamie Woych
Jamie Woych
MTMaria Antonietta Tosches
Maria Antonietta Tosches
Salamanders have outstanding regenerative abilities, which tend to decline in post-metamorphic life stages. Among various tissues, these amphibians can regenerate the brain from ependymoglia cells, an adult neural stem cell population. Ependymoglia cells are heterogeneous; yet, whether ependymoglia cell diversity underlies variation of regenerative capacity across brain regions and life cycle stages remains poorly studied. Here we present a cell type comparison of regeneration in the pallium (dorsal telencephalon) of pre- and post-metamorphic newts. We found that ependymoglia cells exist in a continuum of cell states ranging from active proliferation to quiescence across life cycle stages, with a deep quiescence state featuring expression of mammalian astrocyte genes. Ependymoglia cell state changes are associated with a slower onset of proliferation and neurogenesis in post-metamorphic animals. Comparisons with developmental and adult neurogenesis reveal that pallial ependymoglia cells retain regional restrictions but can override temporal fate restrictions in response to an injury, producing neurons that are normally born only in early development. We thus find that brain regeneration in newts is not a simple amplification of adult neurogenesis, but a distinct process where the initial molecular state of ependymoglia cells biases the relative proportions of regenerated neuron types. Our findings establish post-metamorphic newts as a system to study how astrocyte-like glial cells can activate a neurogenic program in response to brain injury.

16 January 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JCJonathan Chin Cheong
Jonathan Chin Cheong
SDSimon Van Deursen
Simon Van Deursen
DADreyton Amador
Dreyton Amador
SHShannon Hiner
Shannon Hiner
YWYvon Woappi
Yvon Woappi
Deep skin wounds demand tightly coordinated communication across diverse tissue systems, yet knowledge of the molecular logic governing organ-scale injury response remains incomplete. Existing wound atlases profile fragments of this process, capturing limited tissue groups and healing phases, obscuring how whole organs synchronize repair. Here, we present the Organ-Scale Wound Healing Atlas (OWHA), a 4D multimodal omnibus that integrates snRNA-seq, scRNA-seq, CITE-seq and high-definition spatial transcriptomics to reconstruct the complete spatial and temporal choreography of mammalian wound healing at single cell resolution. OWHA profiles over 725,000 murine single-cell and spatial transcriptomes encompassing the entire wound healing process from early to late healing phases across the vast skin microanatomical tissue niches. This omnibus overcomes long-standing technical limitations, enabling robust resolution of adipocytes, Schwann cells, fragile epithelial intermediates, and over 100 precisely annotated cell states, including populations missed in prior wound databases. This revealed that wound repair proceeds through sharp transcriptional and cellular inflection points driven by Central Orchestrator populations that coordinate healing via synchronized transcriptional activation and direct cross-tissue signaling. Key among these is a Sox6 + Tspear + Il20ra + keratinocyte subpopulation (Basal IV), detectable only through snRNA-seq but entirely missed by conventional wound atlasing. After injury, Basal IV cells deviate from canonical differentiation programs and adopt a neurovasculogenic signaling state during the proliferation phase, forming a transient spatially privileged regulatory hub at the wound edge. This epithelial-anchored niche spatially aligns Basal IV keratinocytes with proliferative endothelial cells, Pericytes, and Repair Schwann Cells, synchronizing re-epithelialization, angiogenesis, and neurite guidance. Mechanistically, this is orchestrated by a conserved Sema3C–Nrp1/Nrp2 axis that coordinates epithelial–vascular–neuronal crosstalk at the wound site. Cross-species integration confirms that the Basal IV/SEMA3C axis is conserved in human skin, yet undetected by conventional scRNA-seq human atlases due to dissociation-induced artifacts – underscoring the critical need for multimodal atlasing to accurately capture organ-scale physiology. Notably, the Basal IV/SEMA3C circuitry is selectively disrupted in human diabetic wounds, but topical Sema3C treatments restores peri-wound angiogenic sprouting and accelerates re-epithelialization of diabetic ulcers in vivo . OWHA establishes the first 4D, organ-scale molecular blueprint of mammalian wound healing, creating a foundational platform for decoding systems-level principles of repair and regeneration for tissue wounds.

20 September 2025 in bioRxiv
Verified
Preprint
Open access
DADreyton G Amador
Dreyton G Amador
JPJustin Anthony Powers
Justin Anthony Powers
ANAshley G. Njiru
Ashley G. Njiru
ZAZahra Ansari
Zahra Ansari
YWYvon Woappi
Yvon Woappi
Cancer cell evasion of therapy is a highly adaptive process that undermines the efficacy of many treatment strategies. A significant milestone in the study of these mechanisms has been the advent of pooled CRISPR knockout screens, which enable high-throughput, genome-wide interrogations of tumor dependencies and synthetic lethal interactions, advancing our understanding of how cancer cells adapt to and evade therapies. However, the utility of this approach diminishes when applied to dynamic biological contexts, where processes are transient and sensitive to routine cell culture manipulations that introduce noise and limit meaningful discoveries. To overcome these limitations, we present RESTRICT-seq, a next-generation pooled screening methodology that restricts Cas9 nuclear activation in controlled, repeated cycles. By confining Cas9 catalytic activity to strict temporal windows, RESTRICT-seq mitigates undesired fitness penalties that accumulate throughout CRISPR screens. When benchmarked against conventional pooled screens and standard inducible CRISPR protocols, RESTRICT-seq revealed significantly fewer divergent cell clones and increased signal-to-noise ratio, overcoming a key limitation of traditional methods. Leveraging RESTRICT-seq, we conducted a comprehensive functional survey of the druggable mammalian epigenome, uncovering several elusive epigenetic drivers of treatment resistance in cutaneous squamous cell carcinoma (cSCC). This revealed PAK1 as a previously unrecognized mediator of cSCC resistance in human and mouse SCC, offering new insights into a prognostic marker and therapeutic target of high clinical significance. Our findings establish RESTRICT-seq as a powerful tool for extending the applicability of pooled CRISPR screens to dynamic and previously intractable biological contexts.